Raloxifene Hydrochloride

Overview

Raloxifene Hydrochloride is a selective estrogen receptor modulator (SERM) used primarily for the prevention and treatment of osteoporosis in postmenopausal women. In addition, it is used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and those at high risk for invasive breast cancer.

API suppliers (11)

Suppliers of Raloxifene Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV1 active DMF
• ERREGIERRE SPAItaly1 active DMF
• ERREGIERRE SPAItaly1 active DMF
• ERREGIERRE SPAItaly1 active DMF
• OLON SPAItaly1 active DMF
• INVENTAA INDUSTRIES PRIVATE LTD1 active DMF
• INVENTAA INDUSTRIES PRIVATE LTD1 active DMF
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
• Sichuan Baili Pharmaceutical Co., Ltd.China
• EXCELLA GMBH
• Cipla USA, Inc.USA

Therapeutic areas